1
|
Sinonquel P, Bossuyt P, Sabino JPG, Verstockt B, Makino T, Vermeire S, Bisschops R. Long-term follow-up of the red density pilot trial: a basis for long-term prediction of sustained clinical remission in ulcerative colitis? Endosc Int Open 2023; 11:E880-E884. [PMID: 38223521 PMCID: PMC10784805 DOI: 10.1055/a-2153-7210] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/29/2023] [Accepted: 08/10/2023] [Indexed: 01/16/2024] Open
Abstract
Red density (RD) technology is an automated operator-independent endoscopic scoring system for disease activity in ulcerative colitis (UC). In this retrospective analysis we aimed to assess the predictive value of the RD sore for sustained clinical remission. All 39 patients from the RD pilot trial were evaluated for clinical outcome in a 5-year period. The highest RD score was considered for Receiver operating characteristic (ROC) analysis to determine the cut-off of the RD for the composite endpoint of treatment failure (defined as mortality, colectomy, hospitalizations, flares and UC therapy changes). Statistical significance was considered P < 0.05. Reassessment of the RD score was possible in 36 patients. The composite endpoint was reached in 17 of 39 patients. ROC analysis for clinical remission showed a RD cut-off of 65, area under the ROC was 0.68, sensitivity of 0.71, and a specificity of 0.63. A RD score of ≥ 65 demonstrated a statistically non-significant increase in composite endpoint (hazard ratio 0.49 (95% confidence interval 0.1871-1.280); P = 0.1453). In conclusion, the RD score may be an independent predictor of clinical remission in patients with UC for the disease course up to 5 years, but results of the ongoing PROCEED-UC trial are to awaited for definite conclusions.
Collapse
Affiliation(s)
- Pieter Sinonquel
- Department of Translational Research in Gastrointestinal Disorders (TARGID), KU Leuven, Leuven, Belgium
- Department of Gastroenterology and Hepatology, KU Leuven University Hospitals Leuven Gasthuisberg Campus, Leuven, Belgium
| | - Peter Bossuyt
- Department of Gastroenterology and Hepatology, KU Leuven University Hospitals Leuven Gasthuisberg Campus, Leuven, Belgium
- Gastroenterology, Imelda General Hospital, Bonheiden, Bonheiden, Belgium
| | - João Pedro Guedelha Sabino
- Department of Translational Research in Gastrointestinal Disorders (TARGID), KU Leuven, Leuven, Belgium
- Department of Gastroenterology and Hepatology, KU Leuven University Hospitals Leuven Gasthuisberg Campus, Leuven, Belgium
| | - Bram Verstockt
- Department of Translational Research in Gastrointestinal Disorders (TARGID), KU Leuven, Leuven, Belgium
- Department of Gastroenterology and Hepatology, KU Leuven University Hospitals Leuven Gasthuisberg Campus, Leuven, Belgium
| | - Takao Makino
- Pentax Life Care Division, Hoya Corporation Showanomori Technical Center Pentax Life Care Division, Akishima, Japan
| | - Severine Vermeire
- Department of Translational Research in Gastrointestinal Disorders (TARGID), KU Leuven, Leuven, Belgium
- Department of Gastroenterology and Hepatology, KU Leuven University Hospitals Leuven Gasthuisberg Campus, Leuven, Belgium
| | - Raf Bisschops
- Department of Translational Research in Gastrointestinal Disorders (TARGID), KU Leuven, Leuven, Belgium
- Department of Gastroenterology and Hepatology, KU Leuven University Hospitals Leuven Gasthuisberg Campus, Leuven, Belgium
| |
Collapse
|
2
|
Abstract
INTRODUCTION Diagnosis and therapeutic management in ulcerative colitis (UC) relies on a combination of endoscopic and histological scorings which are difficult to objectively quantify. Artificial intelligence (AI) might overcome the current issues of inter-observer variability, repetitive need for biopsies and estimation of disease activity medicine currently encourages. AREAS COVERED With this narrative literature review we aim to provide a clear and critical overview of the recent evolutions in the field of AI and UC, based on a literature search performed on Pubmed, Embase and Cochrane Library. The major focus of this review is the use of AI for endoscopic assessment of disease activity and the correlation with histology and long-term outcome. Moreover, we elucidate on the more recent developments in the field of AI as support in histological disease assessment, surveillance, therapy monitoring and natural language processing. EXPERT OPINION UC management is evolving with AI impacting nearly every aspect of it. The immediate future influence of AI in UC management will be focussed on the collection, extraction and organization of particular clinical information. Expect is the transformation toward a real-time standardized, reproducible, objective and high-reliable disease grading, especially in endoscopy, histology and eventually radiology applications for UC.
Collapse
Affiliation(s)
- Pieter Sinonquel
- Department of Gastroenterology and Hepatology, UZ Leuven, Leuven, Belgium.,Department of Translational Research in Gastrointestinal Disorders (TARGID), KU Leuven, Leuven, Belgium
| | | | - Bram Verstockt
- Department of Gastroenterology and Hepatology, UZ Leuven, Leuven, Belgium.,Department of Translational Research in Gastrointestinal Disorders (TARGID), KU Leuven, Leuven, Belgium
| | - Séverine Vermeire
- Department of Gastroenterology and Hepatology, UZ Leuven, Leuven, Belgium.,Department of Translational Research in Gastrointestinal Disorders (TARGID), KU Leuven, Leuven, Belgium
| | - Raf Bisschops
- Department of Gastroenterology and Hepatology, UZ Leuven, Leuven, Belgium.,Department of Translational Research in Gastrointestinal Disorders (TARGID), KU Leuven, Leuven, Belgium
| |
Collapse
|
3
|
Messmann H, Bisschops R, Antonelli G, Libânio D, Sinonquel P, Abdelrahim M, Ahmad OF, Areia M, Bergman JJGHM, Bhandari P, Boskoski I, Dekker E, Domagk D, Ebigbo A, Eelbode T, Eliakim R, Häfner M, Haidry RJ, Jover R, Kaminski MF, Kuvaev R, Mori Y, Palazzo M, Repici A, Rondonotti E, Rutter MD, Saito Y, Sharma P, Spada C, Spadaccini M, Veitch A, Gralnek IM, Hassan C, Dinis-Ribeiro M. Expected value of artificial intelligence in gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy 2022; 54:1211-1231. [PMID: 36270318 DOI: 10.1055/a-1950-5694] [Citation(s) in RCA: 37] [Impact Index Per Article: 18.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Abstract
This ESGE Position Statement defines the expected value of artificial intelligence (AI) for the diagnosis and management of gastrointestinal neoplasia within the framework of the performance measures already defined by ESGE. This is based on the clinical relevance of the expected task and the preliminary evidence regarding artificial intelligence in artificial or clinical settings. MAIN RECOMMENDATIONS:: (1) For acceptance of AI in assessment of completeness of upper GI endoscopy, the adequate level of mucosal inspection with AI should be comparable to that assessed by experienced endoscopists. (2) For acceptance of AI in assessment of completeness of upper GI endoscopy, automated recognition and photodocumentation of relevant anatomical landmarks should be obtained in ≥90% of the procedures. (3) For acceptance of AI in the detection of Barrett's high grade intraepithelial neoplasia or cancer, the AI-assisted detection rate for suspicious lesions for targeted biopsies should be comparable to that of experienced endoscopists with or without advanced imaging techniques. (4) For acceptance of AI in the management of Barrett's neoplasia, AI-assisted selection of lesions amenable to endoscopic resection should be comparable to that of experienced endoscopists. (5) For acceptance of AI in the diagnosis of gastric precancerous conditions, AI-assisted diagnosis of atrophy and intestinal metaplasia should be comparable to that provided by the established biopsy protocol, including the estimation of extent, and consequent allocation to the correct endoscopic surveillance interval. (6) For acceptance of artificial intelligence for automated lesion detection in small-bowel capsule endoscopy (SBCE), the performance of AI-assisted reading should be comparable to that of experienced endoscopists for lesion detection, without increasing but possibly reducing the reading time of the operator. (7) For acceptance of AI in the detection of colorectal polyps, the AI-assisted adenoma detection rate should be comparable to that of experienced endoscopists. (8) For acceptance of AI optical diagnosis (computer-aided diagnosis [CADx]) of diminutive polyps (≤5 mm), AI-assisted characterization should match performance standards for implementing resect-and-discard and diagnose-and-leave strategies. (9) For acceptance of AI in the management of polyps ≥ 6 mm, AI-assisted characterization should be comparable to that of experienced endoscopists in selecting lesions amenable to endoscopic resection.
Collapse
Affiliation(s)
- Helmut Messmann
- III Medizinische Klinik, Universitatsklinikum Augsburg, Augsburg, Germany
| | - Raf Bisschops
- Department of Gastroenterology and Hepatology, Catholic University of Leuven (KUL), TARGID, University Hospital Leuven, Leuven, Belgium
| | - Giulio Antonelli
- Gastroenterology and Digestive Endoscopy Unit, Ospedale dei Castelli Hospital, Ariccia, Rome, Italy
- Department of Anatomical, Histological, Forensic Medicine and Orthopedics Sciences, Sapienza University of Rome, Italy
| | - Diogo Libânio
- Department of Gastroenterology, Porto Comprehensive Cancer Center, and RISE@CI-IPOP (Health Research Network), Porto, Portugal
- MEDCIDS, Faculty of Medicine, University of Porto, Porto, Portugal
| | - Pieter Sinonquel
- Department of Gastroenterology and Hepatology, Catholic University of Leuven (KUL), TARGID, University Hospital Leuven, Leuven, Belgium
| | - Mohamed Abdelrahim
- Endoscopy Department, Portsmouth Hospitals University NHS Trust, Portsmouth, UK
| | - Omer F Ahmad
- Wellcome/EPSRC Centre for Interventional and Surgical Sciences, University College London Hospital, London, UK
- Division of Surgery and Interventional Sciences, University College London Hospital, London, UK
- Gastrointestinal Services, University College London Hospital, London, UK
| | - Miguel Areia
- Gastroenterology Department, Portuguese Oncology Institute of Coimbra, Coimbra, Portugal
| | | | - Pradeep Bhandari
- Endoscopy Department, Portsmouth Hospitals University NHS Trust, Portsmouth, UK
| | - Ivo Boskoski
- Digestive Endoscopy Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
| | - Evelien Dekker
- Department of Gastroenterology and Hepatology, Amsterdam UMC, Amsterdam, The Netherlands
| | - Dirk Domagk
- Department of Medicine I, Josephs-Hospital Warendorf, Academic Teaching Hospital, University of Muenster, Warendorf, Germany
| | - Alanna Ebigbo
- III Medizinische Klinik, Universitatsklinikum Augsburg, Augsburg, Germany
| | - Tom Eelbode
- Department of Electrical Engineering (ESAT/PSI), Medical Imaging Research Center, KU Leuven, Leuven, Belgium
| | - Rami Eliakim
- Department of Gastroenterology, Sheba Medical Center Tel Hashomer & Sackler School of Medicine, Tel-Aviv University, Ramat Gan, Israel
| | - Michael Häfner
- 2nd Medical Department, Barmherzige Schwestern Krankenhaus, Vienna, Austria
| | - Rehan J Haidry
- Wellcome/EPSRC Centre for Interventional and Surgical Sciences, University College London Hospital, London, UK
- Division of Surgery and Interventional Sciences, University College London Hospital, London, UK
| | - Rodrigo Jover
- Servicio de Gastroenterología, Hospital General Universitario Dr. Balmis, Instituto de Investigación Biomédica de Alicante ISABIAL, Departamento de Medicina Clínica, Universidad Miguel Hernández, Alicante, Spain
| | - Michal F Kaminski
- Clinical Effectiveness Research Group, University of Oslo, Oslo, Norway
- Department of Gastroenterology, Hepatology and Clinical Oncology, Centre of Postgraduate Medical Education, Warsaw, Poland
- Department of Oncological Gastroenterology and Department of Cancer Prevention, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
| | - Roman Kuvaev
- Endoscopy Department, Yaroslavl Regional Cancer Hospital, Yaroslavl, Russian Federation
- Department of Gastroenterology, Faculty of Additional Professional Education, N.A. Pirogov Russian National Research Medical University, Moscow, Russian Federation
| | - Yuichi Mori
- Clinical Effectiveness Research Group, University of Oslo, Oslo, Norway
- Digestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan
| | | | - Alessandro Repici
- Department of Biomedical Sciences, Humanitas University, Rozzano, Milan, Italy
- IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
| | | | - Matthew D Rutter
- North Tees and Hartlepool NHS Foundation Trust, Stockton-on-Tees, UK
- Population Health Sciences Institute, Newcastle University, Newcastle, UK
| | - Yutaka Saito
- Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan
| | - Prateek Sharma
- Gastroenterology and Hepatology Division, University of Kansas School of Medicine, Kansas, USA
- Kansas City VA Medical Center, Kansas City, USA
| | - Cristiano Spada
- Digestive Endoscopy Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
- Digestive Endoscopy, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy
| | - Marco Spadaccini
- Department of Biomedical Sciences, Humanitas University, Rozzano, Milan, Italy
- IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
| | - Andrew Veitch
- Department of Gastroenterology, Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, UK
| | - Ian M Gralnek
- Ellen and Pinchas Mamber Institute of Gastroenterology and Hepatology, Emek Medical Center, Afula, Israel
- Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
| | - Cesare Hassan
- Department of Biomedical Sciences, Humanitas University, Rozzano, Milan, Italy
- IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
| | - Mario Dinis-Ribeiro
- Department of Gastroenterology, Porto Comprehensive Cancer Center, and RISE@CI-IPOP (Health Research Network), Porto, Portugal
| |
Collapse
|
4
|
Sinonquel P, Vermeire S, Maes F, Bisschops R. Advanced Imaging in Gastrointestinal Endoscopy: A Literature Review of the Current State of the Art. GE Port J Gastroenterol 2022. [DOI: 10.1159/000527083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
<b><i>Background and Aims:</i></b> Gastrointestinal (GI) endoscopy has known a great evolution in the last decades. Imaging techniques evolved from imaging with only standard white light endoscopes toward high-definition resolution endoscopes and the use of multiple color enhancement techniques, over to automated endoscopic assessment systems based on artificial intelligence. This narrative literature review aimed to provide a detailed overview on the latest evolutions within the field of advanced GI endoscopy, mainly focusing on the screening, diagnosis, and surveillance of common upper and lower GI pathology. <b><i>Methods:</i></b> This review comprises only literature about screening, diagnosis, and surveillance strategies using advanced endoscopic imaging techniques published in (inter)national peer-reviewed journals and written in English. Studies with only adult patients included were selected. A search was performed using MESH terms: dye-based chromoendoscopy, virtual chromoendoscopy, video enhancement technique, upper GI tract, lower GI tract, Barrett’s esophagus, esophageal squamous cell carcinoma, gastric cancer, colorectal polyps, inflammatory bowel disease, artificial intelligence. This review does not elaborate on the therapeutic application or impact of advanced GI endoscopy. <b><i>Conclusions:</i></b> Focusing on current and future applications and evolutions in the field of both upper and lower GI advanced endoscopy, this overview is a practical but detailed projection of the latest developments. Within this review, an active leap toward artificial intelligence and its recent developments in GI endoscopy was made. Additionally, the literature is weighted against the current international guidelines and assessed for its potential positive future impact.
Collapse
|
5
|
Engelen MM, Vandenbriele C, Spalart V, Martens CP, Vandenberk B, Sinonquel P, Lorent N, De Munter P, Willems R, Wauters J, Wilmer A, Dauwe D, Gunst J, Guler I, Janssens S, Martinod K, Pieters G, Peerlinck K, Verhamme P, Vanassche T. Thromboprophylaxis in COVID‐19: Weight and severity adjusted intensified dosing. Res Pract Thromb Haemost 2022; 6:e12683. [PMID: 35415384 PMCID: PMC8980774 DOI: 10.1002/rth2.12683] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2021] [Revised: 01/19/2022] [Accepted: 01/24/2022] [Indexed: 12/22/2022] Open
Abstract
Background Aims Methods Results Conclusion
Collapse
Affiliation(s)
- Matthias M. Engelen
- Department of Cardiovascular Diseases University Hospitals Leuven Leuven Belgium
- Center for Molecular and Vascular Biology Department of Cardiovascular Sciences KU Leuven Leuven Belgium
| | - Christophe Vandenbriele
- Department of Cardiovascular Diseases University Hospitals Leuven Leuven Belgium
- Center for Molecular and Vascular Biology Department of Cardiovascular Sciences KU Leuven Leuven Belgium
| | - Valérie Spalart
- Department of Cardiovascular Diseases University Hospitals Leuven Leuven Belgium
- Center for Molecular and Vascular Biology Department of Cardiovascular Sciences KU Leuven Leuven Belgium
| | - Caroline P. Martens
- Center for Molecular and Vascular Biology Department of Cardiovascular Sciences KU Leuven Leuven Belgium
| | - Bert Vandenberk
- Department of Cardiovascular Diseases University Hospitals Leuven Leuven Belgium
| | - Pieter Sinonquel
- Department of Gastro‐enterology and Hepatology University Hospitals Leuven Leuven Belgium
- Department of Translational Research in Gastrointestinal Diseases (TARGID) KU Leuven Leuven Belgium
| | - Natalie Lorent
- Department of Respiratory Diseases University Hospitals Leuven Leuven Belgium
| | - Paul De Munter
- Department of General Internal Medicine University Hospitals Leuven Leuven Belgium
- Department of Microbiology, Immunology and Transplantation KU Leuven Leuven Belgium
| | - Rik Willems
- Department of Cardiovascular Diseases University Hospitals Leuven Leuven Belgium
- Division of Clinical Cardiology, Department of Cardiovascular Sciences KU Leuven Leuven Belgium
| | - Joost Wauters
- Medical Intensive Care Unit Department of General Internal Medicine University Hospitals Leuven Leuven Belgium
| | - Alexander Wilmer
- Medical Intensive Care Unit Department of General Internal Medicine University Hospitals Leuven Leuven Belgium
| | - Dieter Dauwe
- Department of Intensive Care Medicine University Hospitals Leuven Leuven Belgium
| | - Jan Gunst
- Department of Intensive Care Medicine University Hospitals Leuven Leuven Belgium
- Laboratory of Intensive Care Medicine Department of Cellular and Molecular Medicine KU Leuven Leuven Belgium
| | - Ipek Guler
- Leuven Biostatistics and Statistical Bioinformatics Centre (L‐BioStat) KU Leuven Leuven Belgium
| | - Stefan Janssens
- Department of Cardiovascular Diseases University Hospitals Leuven Leuven Belgium
| | - Kimberly Martinod
- Center for Molecular and Vascular Biology Department of Cardiovascular Sciences KU Leuven Leuven Belgium
| | - Griet Pieters
- Department of Cardiovascular Diseases University Hospitals Leuven Leuven Belgium
| | - Kathelijne Peerlinck
- Department of Cardiovascular Diseases University Hospitals Leuven Leuven Belgium
- Center for Molecular and Vascular Biology Department of Cardiovascular Sciences KU Leuven Leuven Belgium
| | - Peter Verhamme
- Department of Cardiovascular Diseases University Hospitals Leuven Leuven Belgium
- Center for Molecular and Vascular Biology Department of Cardiovascular Sciences KU Leuven Leuven Belgium
| | - Thomas Vanassche
- Department of Cardiovascular Diseases University Hospitals Leuven Leuven Belgium
- Center for Molecular and Vascular Biology Department of Cardiovascular Sciences KU Leuven Leuven Belgium
| |
Collapse
|
6
|
Huang IH, Sinonquel P, Verbeure W, Camps C, Devriese H, Holvoet L, Verstockt B, Willekens H, Mori H, Bisschops R, Tack J. Impact on aerosol generation during upper endoscopy of mouthpiece designed to reduce COVID-19 droplet spread: single-center randomized controlled trial. Endoscopy 2022; 54:81-83. [PMID: 34820823 DOI: 10.1055/a-1664-8562] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/10/2022]
Affiliation(s)
- I-Hsuan Huang
- Translational Research Center for Gastrointestinal Disorders, KU Leuven, Leuven, Belgium.,Tri-Service General Hospital, National Defense Medical Center, Taiwan
| | - Pieter Sinonquel
- Translational Research Center for Gastrointestinal Disorders, KU Leuven, Leuven, Belgium.,Department of Gastroenterology and Hepatology, UZ Leuven, Leuven, Belgium
| | - Wout Verbeure
- Translational Research Center for Gastrointestinal Disorders, KU Leuven, Leuven, Belgium
| | - Chelsea Camps
- Department of Gastroenterology and Hepatology, UZ Leuven, Leuven, Belgium
| | - Herman Devriese
- Prevention and Environment, Leuven University Hospital, Leuven, Belgium
| | - Lieselot Holvoet
- Department of Gastroenterology and Hepatology, UZ Leuven, Leuven, Belgium
| | - Bram Verstockt
- Translational Research Center for Gastrointestinal Disorders, KU Leuven, Leuven, Belgium.,Department of Gastroenterology and Hepatology, UZ Leuven, Leuven, Belgium
| | - Hilde Willekens
- Department of Gastroenterology and Hepatology, UZ Leuven, Leuven, Belgium
| | - Hideki Mori
- Translational Research Center for Gastrointestinal Disorders, KU Leuven, Leuven, Belgium
| | - Raf Bisschops
- Translational Research Center for Gastrointestinal Disorders, KU Leuven, Leuven, Belgium.,Department of Gastroenterology and Hepatology, UZ Leuven, Leuven, Belgium
| | - Jan Tack
- Translational Research Center for Gastrointestinal Disorders, KU Leuven, Leuven, Belgium.,Department of Gastroenterology and Hepatology, UZ Leuven, Leuven, Belgium
| |
Collapse
|
7
|
Engelen MM, Vandenbriele C, Balthazar T, Claeys E, Gunst J, Guler I, Jacquemin M, Janssens S, Lorent N, Liesenborghs L, Peerlinck K, Pieters G, Rex S, Sinonquel P, Van der Linden L, Van Laer C, Vos R, Wauters J, Wilmer A, Verhamme P, Vanassche T. Venous Thromboembolism in Patients Discharged after COVID-19 Hospitalization. Semin Thromb Hemost 2021; 47:362-371. [PMID: 33893631 DOI: 10.1055/s-0041-1727284] [Citation(s) in RCA: 51] [Impact Index Per Article: 17.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
BACKGROUND Venous thromboembolism (VTE) is a frequent complication of COVID-19, so that the importance of adequate in-hospital thromboprophylaxis in patients hospitalized with COVID-19 is well established. However, the incidence of VTE after discharge and whether postdischarge thromboprophylaxis is beneficial and safe are unclear. In this prospective observational single-center study, we report the incidence of VTE 6 weeks after hospitalization and the use of postdischarge thromboprophylaxis. METHODS Patients hospitalized with confirmed COVID-19 were invited to a multidisciplinary follow-up clinic 6 weeks after discharge. D-dimer and C-reactive protein were measured, and all patients were screened for deep vein thrombosis with venous duplex-ultrasound. Additionally, selected high-risk patients received computed tomography pulmonary angiogram or ventilation-perfusion (V/Q) scan to screen for incidental pulmonary embolism. RESULTS Of 485 consecutive patients hospitalized from March through June 2020, 146 patients were analyzed, of which 39% had been admitted to the intensive care unit (ICU). Postdischarge thromboprophylaxis was prescribed in 28% of patients, but was used more frequently after ICU stay (61%) and in patients with higher maximal D-dimer and C-reactive protein levels during hospitalization. Six weeks after discharge, elevated D-dimer values were present in 32% of ward and 42% of ICU patients. Only one asymptomatic deep vein thrombosis (0.7%) and one symptomatic pulmonary embolism (0.7%) were diagnosed with systematic screening. No bleedings were reported. CONCLUSION In patients who had been hospitalized with COVID-19, systematic screening for VTE 6 weeks after discharge revealed a low incidence of VTE. A strategy of selectively providing postdischarge thromboprophylaxis in high-risk patients seems safe and potentially effective.
Collapse
Affiliation(s)
- Matthias M Engelen
- Department of Cardiovascular Diseases, University Hospitals Leuven, Leuven, Belgium
| | | | - Tim Balthazar
- Department of Cardiovascular Diseases, University Hospitals Leuven, Leuven, Belgium
| | - Eveline Claeys
- Department of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium
| | - Jan Gunst
- Clinical Department and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium
| | - Ipek Guler
- Leuven Biostatistics and Statistical Bioinformatics Centre (L-BioStat), KU Leuven, Leuven, Belgium
| | - Marc Jacquemin
- Department of Cardiovascular Diseases and Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium
| | - Stefan Janssens
- Department of Cardiovascular Diseases, University Hospitals Leuven, Leuven, Belgium
| | - Natalie Lorent
- Department of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium
| | - Laurens Liesenborghs
- Department of Cardiovascular Diseases, University Hospitals Leuven, Leuven, Belgium.,The Outbreak Research Team, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium
| | - Kathelijne Peerlinck
- Department of Cardiovascular Diseases, University Hospitals Leuven, Leuven, Belgium
| | - Griet Pieters
- Department of Cardiovascular Diseases, University Hospitals Leuven, Leuven, Belgium
| | - Steffen Rex
- Department of Anesthesiology, University Hospitals Leuven, Leuven, Belgium.,Department of Cardiovascular Diseases, KU Leuven, Leuven, Belgium
| | - Pieter Sinonquel
- Department of Internal Medicine, University Hospitals Leuven, Leuven, Belgium
| | - Lorenz Van der Linden
- Pharmacy Department, University Hospitals Leuven, Leuven, Belgium.,Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
| | - Christine Van Laer
- Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium
| | - Robin Vos
- Department of CHROMETA, Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), KU Leuven, Leuven, Belgium
| | - Joost Wauters
- Medical Intensive Care, University Hospitals Leuven, Leuven, Belgium
| | - Alexander Wilmer
- Medical Intensive Care, University Hospitals Leuven, Leuven, Belgium
| | - Peter Verhamme
- Department of Cardiovascular Diseases, University Hospitals Leuven, Leuven, Belgium
| | - Thomas Vanassche
- Department of Cardiovascular Diseases, University Hospitals Leuven, Leuven, Belgium
| |
Collapse
|
8
|
Sinonquel P, Eelbode T, Hassan C, Antonelli G, Filosofi F, Neumann H, Demedts I, Roelandt P, Maes F, Bisschops R. Real-time unblinding for validation of a new CADe tool for colorectal polyp detection. Gut 2021; 70:641-643. [PMID: 33046559 DOI: 10.1136/gutjnl-2020-322491] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/09/2020] [Accepted: 07/23/2020] [Indexed: 12/21/2022]
Affiliation(s)
- Pieter Sinonquel
- Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.,Department of Translational Research in Gastrointestinal Diseases (TARGID), KU Leuven, Leuven, Belgium
| | - Tom Eelbode
- Department of Electrical Engineering (ESAT/PSI), Medical Imaging Research Center, KU Leuven, Leuven, Belgium
| | - Cesare Hassan
- Digestive Endoscopy Unit, Nuovo Regina Margherita Hospital, Rome, Italy
| | - Giulio Antonelli
- Digestive Endoscopy Unit, Nuovo Regina Margherita Hospital, Rome, Italy
| | - Federica Filosofi
- Digestive Endoscopy Unit, Nuovo Regina Margherita Hospital, Rome, Italy
| | - Helmut Neumann
- Department of Gastroenterology and Hepatology, University Medical Center Mainz, Mainz, Germany
| | - Ingrid Demedts
- Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.,Department of Translational Research in Gastrointestinal Diseases (TARGID), KU Leuven, Leuven, Belgium
| | - Philip Roelandt
- Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.,Department of Translational Research in Gastrointestinal Diseases (TARGID), KU Leuven, Leuven, Belgium
| | - Frederik Maes
- Department of Electrical Engineering (ESAT/PSI), Medical Imaging Research Center, KU Leuven, Leuven, Belgium
| | - Raf Bisschops
- Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium .,Department of Translational Research in Gastrointestinal Diseases (TARGID), KU Leuven, Leuven, Belgium
| |
Collapse
|
9
|
Sinonquel P, Eelbode T, Bossuyt P, Maes F, Bisschops R. Artificial intelligence and its impact on quality improvement in upper and lower gastrointestinal endoscopy. Dig Endosc 2021; 33:242-253. [PMID: 33145847 DOI: 10.1111/den.13888] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/28/2020] [Revised: 10/14/2020] [Accepted: 11/01/2020] [Indexed: 12/24/2022]
Abstract
Artificial intelligence (AI) and its application in medicine has grown large interest. Within gastrointestinal (GI) endoscopy, the field of colonoscopy and polyp detection is the most investigated, however, upper GI follows the lead. Since endoscopy is performed by humans, it is inherently an imperfect procedure. Computer-aided diagnosis may improve its quality by helping prevent missing lesions and supporting optical diagnosis for those detected. An entire evolution in AI systems has been established in the last decades, resulting in optimization of the diagnostic performance with lower variability and matching or even outperformance of expert endoscopists. This shows a great potential for future quality improvement of endoscopy, given the outstanding diagnostic features of AI. With this narrative review, we highlight the potential benefit of AI to improve overall quality in daily endoscopy and describe the most recent developments for characterization and diagnosis as well as the recent conditions for regulatory approval.
Collapse
Affiliation(s)
- Pieter Sinonquel
- Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.,Departments of, Department of, Translational Research in Gastrointestinal Diseases (TARGID), KU Leuven, Leuven, Belgium
| | - Tom Eelbode
- Medical Imaging Research Center (MIRC), University Hospitals Leuven, Leuven, Belgium.,Department of Electrical Engineering (ESAT/PSI), KU Leuven, Leuven, Belgium
| | - Peter Bossuyt
- Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.,Department of Gastroenterology and Hepatology, Imelda Hospital, Bonheiden, Belgium
| | - Frederik Maes
- Medical Imaging Research Center (MIRC), University Hospitals Leuven, Leuven, Belgium.,Department of Electrical Engineering (ESAT/PSI), KU Leuven, Leuven, Belgium
| | - Raf Bisschops
- Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.,Departments of, Department of, Translational Research in Gastrointestinal Diseases (TARGID), KU Leuven, Leuven, Belgium
| |
Collapse
|
10
|
Sinonquel P, Bisschops R. Striving for quality improvement: can artificial intelligence help? Best Pract Res Clin Gastroenterol 2020; 52-53:101722. [PMID: 34172249 DOI: 10.1016/j.bpg.2020.101722] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/10/2020] [Accepted: 12/22/2020] [Indexed: 02/06/2023]
Abstract
Artificial intelligence (AI) is of keen interest for global health development as potential support for current human shortcomings. Gastrointestinal (GI) endoscopy is an excellent substrate for AI, since it holds the genuine potential to improve quality in GI endoscopy and overall patient care by improving detection and diagnosis guiding the endoscopists in performing endoscopy to the highest quality standards. The possibility of large data acquisitioning to refine algorithms makes implementation of AI into daily practice a potential reality. With the start of a new era adopting deep learning, large amounts of data can easily be processed, resulting in better diagnostic performances. In the upper gastrointestinal tract, research currently focusses on the detection and characterization of neoplasia, including Barrett's, squamous cell and gastric carcinoma, with an increasing amount of AI studies demonstrating the potential and benefit of AI-augmented endoscopy. Deep learning applied to small bowel video capsule endoscopy also appears to enhance pathology detection and reduce capsule reading time. In the colon, multiple prospective trials including five randomized trials, showed a consistent improvement in polyp and adenoma detection rates, one of the main quality indicators in endoscopy. There are however potential additional roles for AI to assist in quality improvement of endoscopic procedures, training and therapeutic decision making. Further large-scale, multicenter validation trials are required before AI-augmented diagnostic gastrointestinal endoscopy can be integrated into our routine clinical practice.
Collapse
Affiliation(s)
- P Sinonquel
- Department of Gastroenterology and Hepatology, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium; Department of Translational Research in Gastrointestinal Diseases (TARGID), Catholic University Leuven, Herestraat 49, 3000, Leuven, Belgium.
| | - R Bisschops
- Department of Gastroenterology and Hepatology, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium; Department of Translational Research in Gastrointestinal Diseases (TARGID), Catholic University Leuven, Herestraat 49, 3000, Leuven, Belgium.
| |
Collapse
|
11
|
Sinonquel P, Roelandt P, Demedts I, Van Gerven L, Vandenbriele C, Wilmer A, Van Wijngaerden E, Bisschops R. COVID-19 and gastrointestinal endoscopy: What should be taken into account? Dig Endosc 2020; 32:723-731. [PMID: 32335962 PMCID: PMC7267439 DOI: 10.1111/den.13706] [Citation(s) in RCA: 27] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/08/2020] [Revised: 04/19/2020] [Accepted: 04/20/2020] [Indexed: 12/15/2022]
Abstract
On March 11, 2020 the World Health Organization declared COVID-19 pandemic, leading to a subsequent impact on the entire world and health care system. Since the causing Severe Acute Respiratory Syndrome Coronavirus 2 houses in the aerodigestive tract, activities in the gastrointestinal outpatient clinic and endoscopy unit should be limited to emergencies only. Health care professionals are faced with the need to perform endoscopic or endoluminal emergency procedures in patients with a confirmed positive or unknown COVID-19 status. With this report, we aim to provide recommendations and practical relevant information for gastroenterologists based on the limited amount of available data and local experience, to guarantee a high-quality patient care and adequate infection prevention in the gastroenterology clinic.
Collapse
Affiliation(s)
- Pieter Sinonquel
- Department ofGastroenterology and HepatologyUniversity Hospitals LeuvenLeuvenBelgium,Department of Translational Research in Gastrointestinal Diseases (TARGID)Catholic University LeuvenLeuvenBelgium
| | - Philip Roelandt
- Department ofGastroenterology and HepatologyUniversity Hospitals LeuvenLeuvenBelgium
| | - Ingrid Demedts
- Department ofGastroenterology and HepatologyUniversity Hospitals LeuvenLeuvenBelgium
| | - Laura Van Gerven
- Department ofOtorhinolaryngology, Head & Neck SurgeryUniversity Hospitals LeuvenLeuvenBelgium
| | | | - Alexander Wilmer
- Department of Internal MedicineMedical Intensive Care UnitUniversity Hospitals LeuvenLeuvenBelgium
| | | | - Raf Bisschops
- Department ofGastroenterology and HepatologyUniversity Hospitals LeuvenLeuvenBelgium,Department of Translational Research in Gastrointestinal Diseases (TARGID)Catholic University LeuvenLeuvenBelgium
| |
Collapse
|
12
|
Tack J, Schol J, Geeraerts A, Huang I, Mori H, Scarpellini E, Sinonquel P, Carbone F, Colomier E, Geysen H, Jandee S, Moonen A, Pannemans J, Timmermans L, Van den Houte K, Verbeure W, Wauters L, Bisschops R, Hoffman I, Roelandt P, Rommel N, Simren M, Suzuki H, Tornblom H, Verbeke K, Vanuytsel T. A survey on the impact of the COVID-19 pandemic on motility and functional investigations in Europe and considerations for recommencing activities in the early recovery phase. Neurogastroenterol Motil 2020; 32:e13926. [PMID: 32478910 PMCID: PMC7300498 DOI: 10.1111/nmo.13926] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/18/2020] [Revised: 05/27/2020] [Accepted: 05/28/2020] [Indexed: 12/12/2022]
Abstract
BACKGROUND The COVID-19 pandemic, declared by WHO on March 13, 2020, had a major global impact on the healthcare system and services. In the acute phase, the presence of the SARS-CoV-2 virus in the aerodigestive tract limited activities in the gastroenterology clinic and procedures to emergencies only. Motility and function testing was interrupted and as we enter the recovery phase, restarting these procedures requires a safety-focused approach with adequate infection prevention for patients and healthcare professionals. METHODS We summarized knowledge on the presence of the SARS-CoV-2 virus in the aerodigestive tract and the risk of spread with motility and functional testing. We surveyed 39 European centers documenting how the pandemic affected activities and which measures they are considering for restarting these measurements. We propose recommendations based on current knowledge as applied in our center. RESULTS Positioning of catheters for gastrointestinal motility tests carries a concern for aerosol-borne infection of healthcare workers. The risk is low with breath tests. The surveyed centers stopped almost all motility and function tests from the second half of March. The speed of restarting and the safety measures taken varied highly. CONCLUSIONS AND INFERENCES Based on these findings, we provided recommendations and practical relevant information for motility and function test procedures in the COVID-19 pandemic era, to guarantee a high-quality patient care with adequate infection prevention.
Collapse
Affiliation(s)
- Jan Tack
- Translational Research Center for Gastrointestinal Disorders (TARGID)Department of Chronic Diseases, Metabolism and Ageing (CHROMETA)KU LeuvenLeuvenBelgium,Division of Gastroenterology and HepatologyLeuven University HospitalsLeuvenBelgium,Department of Internal Medicine & Clinical NutritionInstitute of MedicineSahlgrenska AcademyUniversity of GothenburgGothenburgSweden
| | - Jolien Schol
- Translational Research Center for Gastrointestinal Disorders (TARGID)Department of Chronic Diseases, Metabolism and Ageing (CHROMETA)KU LeuvenLeuvenBelgium
| | - Annelies Geeraerts
- Translational Research Center for Gastrointestinal Disorders (TARGID)Department of Chronic Diseases, Metabolism and Ageing (CHROMETA)KU LeuvenLeuvenBelgium
| | - I‐Hsuan Huang
- Translational Research Center for Gastrointestinal Disorders (TARGID)Department of Chronic Diseases, Metabolism and Ageing (CHROMETA)KU LeuvenLeuvenBelgium
| | - Hideki Mori
- Translational Research Center for Gastrointestinal Disorders (TARGID)Department of Chronic Diseases, Metabolism and Ageing (CHROMETA)KU LeuvenLeuvenBelgium
| | - Emidio Scarpellini
- Translational Research Center for Gastrointestinal Disorders (TARGID)Department of Chronic Diseases, Metabolism and Ageing (CHROMETA)KU LeuvenLeuvenBelgium
| | - Pieter Sinonquel
- Translational Research Center for Gastrointestinal Disorders (TARGID)Department of Chronic Diseases, Metabolism and Ageing (CHROMETA)KU LeuvenLeuvenBelgium
| | - Florencia Carbone
- Division of Gastroenterology and HepatologyLeuven University HospitalsLeuvenBelgium
| | - Esther Colomier
- Translational Research Center for Gastrointestinal Disorders (TARGID)Department of Chronic Diseases, Metabolism and Ageing (CHROMETA)KU LeuvenLeuvenBelgium
| | - Hannelore Geysen
- Translational Research Center for Gastrointestinal Disorders (TARGID)Department of Chronic Diseases, Metabolism and Ageing (CHROMETA)KU LeuvenLeuvenBelgium
| | - Sawangpong Jandee
- Translational Research Center for Gastrointestinal Disorders (TARGID)Department of Chronic Diseases, Metabolism and Ageing (CHROMETA)KU LeuvenLeuvenBelgium
| | - An Moonen
- Division of Gastroenterology and HepatologyLeuven University HospitalsLeuvenBelgium
| | - Jasper Pannemans
- Translational Research Center for Gastrointestinal Disorders (TARGID)Department of Chronic Diseases, Metabolism and Ageing (CHROMETA)KU LeuvenLeuvenBelgium
| | - Lien Timmermans
- Division of Gastroenterology and HepatologyLeuven University HospitalsLeuvenBelgium
| | - Karen Van den Houte
- Translational Research Center for Gastrointestinal Disorders (TARGID)Department of Chronic Diseases, Metabolism and Ageing (CHROMETA)KU LeuvenLeuvenBelgium
| | - Wout Verbeure
- Translational Research Center for Gastrointestinal Disorders (TARGID)Department of Chronic Diseases, Metabolism and Ageing (CHROMETA)KU LeuvenLeuvenBelgium
| | - Lucas Wauters
- Translational Research Center for Gastrointestinal Disorders (TARGID)Department of Chronic Diseases, Metabolism and Ageing (CHROMETA)KU LeuvenLeuvenBelgium
| | - Raf Bisschops
- Division of Gastroenterology and HepatologyLeuven University HospitalsLeuvenBelgium
| | - Ilse Hoffman
- Division of Gastroenterology and HepatologyLeuven University HospitalsLeuvenBelgium
| | - Philip Roelandt
- Division of Gastroenterology and HepatologyLeuven University HospitalsLeuvenBelgium
| | - Nathalie Rommel
- Division of Gastroenterology and HepatologyLeuven University HospitalsLeuvenBelgium
| | - Magnus Simren
- Department of Internal Medicine & Clinical NutritionInstitute of MedicineSahlgrenska AcademyUniversity of GothenburgGothenburgSweden
| | - Hidekazu Suzuki
- Division of Gastroenterology and HepatologyDepartment of Internal MedicineSchool of MedicineTokai UniversityIseharaKanagawaJapan
| | - Hans Tornblom
- Department of Internal Medicine & Clinical NutritionInstitute of MedicineSahlgrenska AcademyUniversity of GothenburgGothenburgSweden
| | - Kristin Verbeke
- Translational Research Center for Gastrointestinal Disorders (TARGID)Department of Chronic Diseases, Metabolism and Ageing (CHROMETA)KU LeuvenLeuvenBelgium
| | - Tim Vanuytsel
- Translational Research Center for Gastrointestinal Disorders (TARGID)Department of Chronic Diseases, Metabolism and Ageing (CHROMETA)KU LeuvenLeuvenBelgium,Division of Gastroenterology and HepatologyLeuven University HospitalsLeuvenBelgium
| |
Collapse
|
13
|
Van Gerven L, Hellings PW, Cox T, Fokkens W, Hopkins C, Hox V, Jorissen M, Schuermans A, Sinonquel P, Speleman K, Vander Poorten V, Van Gool K, Van Zele T, Alobid I. Personal protection and delivery of rhinologic and endoscopic skull base procedures during the COVID-19 outbreak. Rhinology 2020; 58:289-294. [PMID: 32441710 DOI: 10.4193/rhin20.119] [Citation(s) in RCA: 23] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
On March 11th 2020, the World Health Organization (WHO) declared COVID-19 pandemic, with subsequent profound impact on the entire health care system. During the COVID-19 outbreak, activities in the rhinology outpatient clinic and operation rooms are limited to emergency care only. Health care practitioners are faced with the need to perform rhinological and skull base emergency procedures in patients with a positive or unknown COVID-19 status. This article aims to provide recommendations and relevant information for rhinologists, based on the limited amount of (anecdotal) data, to guarantee high-quality patient care and adequate levels of infection prevention in the rhinology clinic.
Collapse
Affiliation(s)
- L Van Gerven
- University Hospitals Leuven, Department of Otorhinolaryngology, Head and Neck Surgery, Leuven, Belgium
| | - P W Hellings
- University Hospitals Leuven, Department of Otorhinolaryngology, Head and Neck Surgery, Leuven, Belgium; University of Ghent, Department of Otorhinolaryngology, Laboratory of Upper Airways Research, Ghent, Belgium; Academic Medical Center Amsterdam, Department of Otorhinolaryngology, Amsterdam, the Netherlands
| | - T Cox
- Jessa Hospital, Department of Otorhinolaryngology, Head and Neck Surgery, Hasselt, Belgium
| | - W Fokkens
- Academic Medical Center Amsterdam, Department of Otorhinolaryngology, Amsterdam, the Netherlands
| | - C Hopkins
- Guy's and St Thomas’ Hospitals, Department of Otorhinolaryngology, London, United Kingdom
| | - V Hox
- Cliniques Universitaires Saint-Luc, Department of Otorhinolaryngology, Head and Neck Surgery, Brussels, Belgium
| | - M Jorissen
- University Hospitals Leuven, Department of Otorhinolaryngology, Head and Neck Surgery, Leuven, Belgium
| | - A Schuermans
- University Hospitals Leuven, Department of Infection Control and Epidemiology, Leuven, Belgium; KU Leuven, Department of Public Health and Primary Care, Leuven, Belgium
| | - P Sinonquel
- University Hospitals Leuven, Department of Gastro-enterology and Hepatology, Leuven, Belgium
| | - K Speleman
- Sint-Jan Hospital, Department of Otorhinolaryngology, Head and Neck Surgery, Bruges, Belgium
| | - V Vander Poorten
- University Hospitals Leuven, Department of Otorhinolaryngology, Head and Neck Surgery, Leuven, Belgium; University Hospitals Leuven, Department of Oncology, section Head and Neck Oncology, Leuven, Belgium
| | - K Van Gool
- University Hospital Antwerp, Department of Otorhinolaryngology, Head and Neck Surgery, Antwerp, Belgium
| | - T Van Zele
- University of Ghent, Department of Otorhinolaryngology, Laboratory of Upper Airways Research, Ghent, Belgium
| | - I Alobid
- Hospital Clinic Barcelona, Rhinology Unit and Smell Clinic, ENT Department, Centro Medico TEKNON, Barcelona, Spain
| |
Collapse
|
14
|
Sinonquel P, Bossuyt P, Vermeire S, Bisschops R. Betting on quality indicators to improve inflammatory bowel disease surveillance outcome: All-in or one to pick? Dig Endosc 2020; 32:523-525. [PMID: 31774583 DOI: 10.1111/den.13586] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Affiliation(s)
- Pieter Sinonquel
- Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium
| | - Peter Bossuyt
- Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.,Department of Gastroenterology, Imelda Hospital, Bonheiden, Belgium
| | - Séverine Vermeire
- Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium
| | - Raf Bisschops
- Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium
| |
Collapse
|
15
|
Sinonquel P, Aerts M, Badaoui A, Bisschops R, Blero D, Demedts I, Deprez P, Dewint P, Eisendrath P, Hindryckx P, Lemmers A, Roelandt P, Snauwaert C, Toussaint E, Moreels T. BSGIE survey on COVID-19 and gastrointestinal endoscopy in Belgium : results and recommendations. Acta Gastroenterol Belg 2020; 83:344-354. [PMID: 32603061] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
BACKGROUND AND AIMS With the first wave of the COVID-19 pandemic declining, activities in the gastrointestinal clinic are being recommenced after a period of stringent measures. Since a second COVID-19 wave is not entirely ruled out health care professionals might remain faced with the need to perform endoscopic procedures in patients with a confirmed positive or unknown COVID-19 status. With this report we aim to provide a practical relevant overview of preparation and protective measures for gastroenterologists based on the currently available guidelines and our local experience and results of a national Belgian survey, to guarantee a fast recall of an adequate infection prevention if COVID-19 reoccurs. METHODS From the 23rd of March 2020 and the 13th of May 2020 we performed a Pubmed, Embase and Medline search, resulting in 37 papers on COVID-19 and endoscopy. Additionally, we combined these data with data acquired from the national BSGIE survey amongst Belgian gastroenterologists. RESULTS Based on 72 completed surveys in both university and non-university hospitals, the results show (1) a dramatic (<20%) or substantial (<50%) decrease of normal daily endoscopy in 74% and 22% of the units respectively, (2) a difference in screening and protective measures between university and non-university hospitals. These findings were subsequently compared with the current guidelines. CONCLUSION Based on new data from the BSGIE survey and current guidelines we tried to realistically represent the current COVID-19 trends in protective measures, screening and indications for endoscopy and to provide a practical overview as preparation for a possible second wave.
Collapse
Affiliation(s)
- P Sinonquel
- Universitair Ziekenhuis Gasthuisberg, Leuven
| | - M Aerts
- Universitair Ziekenhuis Brussel, Brussels
| | - A Badaoui
- Centre Hospitalier Universitaire de Namur, Namur
| | - R Bisschops
- Universitair Ziekenhuis Gasthuisberg, Leuven
| | | | - I Demedts
- Universitair Ziekenhuis Gasthuisberg, Leuven
| | - P Deprez
- Cliniques Universitaires Saint-Luc, Brussels
| | - P Dewint
- Algemeen Ziekenhuis Maria-Middelares, Ghent
- Universitair Ziekenhuis Antwerpen, Antwerp
| | - P Eisendrath
- Centre Hospitalier Universitaire Saint-Pierre, Brussels
- Hôpital Erasme, Brussels
| | | | | | - Ph Roelandt
- Universitair Ziekenhuis Gasthuisberg, Leuven
| | | | - E Toussaint
- Centre Hospitalier Universitaire de Charleroi, Charleroi
| | - T Moreels
- Cliniques Universitaires Saint-Luc, Brussels
| |
Collapse
|
16
|
Sinonquel P, Bontinck J, Stevens M. Undescended ovary and fallopian tube presenting as appendiceal mucocele. Facts Views Vis Obgyn 2018; 10:47-50. [PMID: 30510668 PMCID: PMC6260671] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
Abstract
Undescended ovary is a rare congenital gynecologic condition, frequently associated with urogenital malformations including unicornuate uterus and ectopic kidneys or renal agenesis. Although ectopic ovaries are mostly found during an infertility work up, its role in infertility is still unknown. We report a 38-year-old patient presenting with pain in the right lower quadrant. Explorative laparoscopy reveals a unicornuate uterus and a malpositioning of the right ovary and distal ending of the right fallopian tube. Through this report, we try to provide hints for guiding the diagnostic management of similar patients in terms of fertility, renal function and tumour formation.
Collapse
Affiliation(s)
- Pieter Sinonquel
- UZ Leuven, Department of Internal medicine, Herestraat 49, 3000 Leuven, Belgium
| | - Julie Bontinck
- Sint-Jozef Kliniek, Department of general and oncological surgery, Kasteelstraat 23, 2880 Bornem, Belgium
| | - Marianne Stevens
- Sint-Jozef Kliniek, Department of gynecology and obstetrics, Kasteelstraat 23, 2880 Bornem, Belgium
| |
Collapse
|